826 related articles for article (PubMed ID: 12945718)
21. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED
J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514
[TBL] [Abstract][Full Text] [Related]
22. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
[TBL] [Abstract][Full Text] [Related]
23. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
Brunner HI; Feldman BM; Bombardier C; Silverman ED
Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
[TBL] [Abstract][Full Text] [Related]
25. Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE.
das Chagas Medeiros MM; Bezerra MC; Braga FN; da Justa Feijão MR; Gois AC; Rebouças VC; de Carvalho TM; Carvalho LN; Ribeiro ÁM
Lupus; 2016 Apr; 25(4):355-63. PubMed ID: 26405022
[TBL] [Abstract][Full Text] [Related]
26. An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins lupus cohort.
Watson P; Brennan A; Birch H; Fang H; Petri M
Rheumatology (Oxford); 2015 Apr; 54(4):623-32. PubMed ID: 25234659
[TBL] [Abstract][Full Text] [Related]
27. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
28. Disease evolution in late-onset and early-onset systemic lupus erythematosus.
Aljohani R; Gladman DD; Su J; Urowitz MB
Lupus; 2017 Oct; 26(11):1190-1196. PubMed ID: 28420066
[TBL] [Abstract][Full Text] [Related]
29. Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis.
Maloney KC; Ferguson TS; Stewart HD; Myers AA; De Ceulaer K
Lupus; 2017 Nov; 26(13):1448-1456. PubMed ID: 28480787
[TBL] [Abstract][Full Text] [Related]
30. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus.
Fang H; Lan L; Qu Y; Zhang Q; Lv J
J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196
[TBL] [Abstract][Full Text] [Related]
31. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
Castrejón I; Tani C; Jolly M; Huang A; Mosca M
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
[TBL] [Abstract][Full Text] [Related]
32. Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus.
Uziel Y; Gorodnitski N; Mukamel M; Padeh S; Brik R; Barash J; Mevorach D; Berkun Y; Tauber T; Press J; Harel L; Navon P; Rubenstein M; Naparstek Y; Hashkes PJ;
Lupus; 2007; 16(2):142-6. PubMed ID: 17402372
[TBL] [Abstract][Full Text] [Related]
33. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus.
Stoll T; Stucki G; Malik J; Pyke S; Isenberg DA
J Rheumatol; 1997 Feb; 24(2):309-13. PubMed ID: 9034988
[TBL] [Abstract][Full Text] [Related]
34. Impact of follow-up adherence on disease activity in childhood-onset systemic lupus erythematosus (cSLE).
Nelson MC; Mosley C; Villacis-Nunez DS; Rouster-Stevens K; Thakral A
Lupus; 2023 May; 32(6):799-803. PubMed ID: 37125694
[TBL] [Abstract][Full Text] [Related]
35. A Multicenter Study of Invasive Fungal Infections in Patients with Childhood-onset Systemic Lupus Erythematosus.
Silva MF; Ferriani MP; Terreri MT; Pereira RM; Magalhães CS; Bonfá E; Campos LM; Okuda EM; Appenzeller S; Ferriani VP; Barbosa CM; Ramos VC; Lotufo S; Silva CA
J Rheumatol; 2015 Dec; 42(12):2296-303. PubMed ID: 26568586
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and clinical significance of anti-ribosomal P antibody in childhood-onset systemic lupus erythematosus.
Aldar H; Lapa AT; Bellini B; Sinicato NA; Postal M; Fernandes PT; Costallat LT; Marini R; Appenzeller S
Lupus; 2012 Oct; 21(11):1225-31. PubMed ID: 22740428
[TBL] [Abstract][Full Text] [Related]
37. Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort.
Medhat BM; Behiry ME; Sobhy N; Farag Y; Marzouk H; Mostafa N; Khalifa I; Elkhalifa M; Eissa BM; Hassan EHE
Clin Rheumatol; 2020 Feb; 39(2):435-442. PubMed ID: 31758421
[TBL] [Abstract][Full Text] [Related]
38. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
Wirestam L; Enocsson H; Skogh T; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace D; Isenberg DA; Rahman A; Merrill J; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma A; Ruiz-Irastorza G; Lim S; Kalunian K; Inanc M; van Vollenhoven R; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken C; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
[TBL] [Abstract][Full Text] [Related]
39. Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years.
Taraborelli M; Cavazzana I; Martinazzi N; Lazzaroni MG; Fredi M; Andreoli L; Franceschini F; Tincani A
Lupus; 2017 Oct; 26(11):1197-1204. PubMed ID: 28420047
[TBL] [Abstract][Full Text] [Related]
40. Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
Kim SK; Choe JY; Lee SS
J Rheumatol; 2017 Apr; 44(4):452-458. PubMed ID: 28298561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
